Alert detail

LCD L38988: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing — Palmetto GBA

Policy ID: LCD-L38988Specialty: Infectious Disease / MicrobiologyAdded: 6/5/2026Effective: July 3, 2025lcd
High

What changed

New guidelines for molecular testing requires billing team review.

Who’s affected: Infectious Disease / Microbiology billing teams · Effective: July 3, 2025

Affected codes

Primary source: View the official CMS/MAC document ↗

Get the action steps and full analysis

This change affects 137 billing codes.

Subscribers get the recommended action (“what to do”), the full AI analysis, the LCD revision comparison, and related alerts across your specialty and jurisdiction.

Audit documentation

Building an audit file?

The Tripwire Audit Pack exports 12 months of Infectious Disease / Microbiology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.

Not ready to subscribe?

Get the free weekly reimbursement brief for Infectious Disease / Microbiology— the week’s changes and deadlines, delivered to your inbox. No account required.

LCD L38988: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing — Palmetto GBA